Corcept Therapeutics Incorporated
Use of glucocorticoid receptor modulators to potentiate checkpoint inhibitors

Abstract:

This invention provides a method that combines a checkpoint inhibitor and a glucocorticoid receptor modulator to treat cancer, e.g., a checkpoint inhibitor sensitive cancer.